These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
357 related articles for article (PubMed ID: 10189324)
21. Background and rationale of the SU.FOL.OM3 study: double-blind randomized placebo-controlled secondary prevention trial to test the impact of supplementation with folate, vitamin B6 and B12 and/or omega-3 fatty acids on the prevention of recurrent ischemic events in subjects with atherosclerosis in the coronary or cerebral arteries. Galan P; de Bree A; Mennen L; Potier de Courcy G; Preziozi P; Bertrais S; Castetbon K; Hercberg S J Nutr Health Aging; 2003; 7(6):428-35. PubMed ID: 14625623 [TBL] [Abstract][Full Text] [Related]
22. Supplementation with omega-3 polyunsaturated fatty acids in the management of recurrent migraines in adolescents. Harel Z; Gascon G; Riggs S; Vaz R; Brown W; Exil G J Adolesc Health; 2002 Aug; 31(2):154-61. PubMed ID: 12127385 [TBL] [Abstract][Full Text] [Related]
23. A prospective, randomized, and double-blind trial on the effect of fish oil on the incidence of restenosis following PTCA. Franzen D; Schannwell M; Oette K; Höpp HW Cathet Cardiovasc Diagn; 1993 Apr; 28(4):301-10. PubMed ID: 8462079 [TBL] [Abstract][Full Text] [Related]
24. Effect of omega-3 fatty acid supplementation on the arachidonic acid:eicosapentaenoic acid ratio. Burns T; Maciejewski SR; Hamilton WR; Zheng M; Mooss AN; Hilleman DE Pharmacotherapy; 2007 May; 27(5):633-8. PubMed ID: 17461697 [TBL] [Abstract][Full Text] [Related]
25. Effects of polyunsaturated omega-3 fatty acids on responsiveness to dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: the OMEGA-PCI (OMEGA-3 fatty acids after pci to modify responsiveness to dual antiplatelet therapy) study. Gajos G; Rostoff P; Undas A; Piwowarska W J Am Coll Cardiol; 2010 Apr; 55(16):1671-8. PubMed ID: 20394870 [TBL] [Abstract][Full Text] [Related]
26. Predictors of change in omega-3 index with fish oil supplementation in peripheral artery disease. Drudi LM; Schaller MS; Hiramoto J; Gasper W; Harris WS; Hills NK; Grenon SM J Surg Res; 2017 Apr; 210():124-131. PubMed ID: 28457318 [TBL] [Abstract][Full Text] [Related]
28. Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation. da Silva TM; Munhoz RP; Alvarez C; Naliwaiko K; Kiss A; Andreatini R; Ferraz AC J Affect Disord; 2008 Dec; 111(2-3):351-9. PubMed ID: 18485485 [TBL] [Abstract][Full Text] [Related]
29. Effects of addition of policosanol to omega-3 fatty acid therapy on the lipid profile of patients with type II hypercholesterolaemia. Castaño G; Fernández L; Mas R; Illnait J; Gámez R; Mendoza S; Mesa M; Fernández J Drugs R D; 2005; 6(4):207-19. PubMed ID: 16050054 [TBL] [Abstract][Full Text] [Related]
30. Clinical and metabolic response to flaxseed oil omega-3 fatty acids supplementation in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial. Soleimani Z; Hashemdokht F; Bahmani F; Taghizadeh M; Memarzadeh MR; Asemi Z J Diabetes Complications; 2017 Sep; 31(9):1394-1400. PubMed ID: 28716357 [TBL] [Abstract][Full Text] [Related]
31. Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial. Brouwer IA; Zock PL; Camm AJ; Böcker D; Hauer RN; Wever EF; Dullemeijer C; Ronden JE; Katan MB; Lubinski A; Buschler H; Schouten EG; JAMA; 2006 Jun; 295(22):2613-9. PubMed ID: 16772624 [TBL] [Abstract][Full Text] [Related]
32. Effect of Omega-3 Polyunsaturated Fatty Acids Supplementation on Body Composition and Circulating Levels of Follistatin-Like 1 in Males With Coronary Artery Disease: A Randomized Double-Blind Clinical Trial. Jafari Salim S; Alizadeh S; Djalali M; Nematipour E; Hassan Javanbakht M Am J Mens Health; 2017 Nov; 11(6):1758-1764. PubMed ID: 28826313 [TBL] [Abstract][Full Text] [Related]
33. A novel, multi-ingredient supplement to manage elevated blood lipids in patients with no evidence of cardiovascular disease: a pilot study. Hobbs T; Caso R; McMahon D; Nymark M Altern Ther Health Med; 2014; 20(5):18-23. PubMed ID: 25141367 [TBL] [Abstract][Full Text] [Related]
34. Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial. Nicholls SJ; Puri R; Anderson T; Ballantyne CM; Cho L; Kastelein JJ; Koenig W; Somaratne R; Kassahun H; Yang J; Wasserman SM; Scott R; Ungi I; Podolec J; Ophuis AO; Cornel JH; Borgman M; Brennan DM; Nissen SE JAMA; 2016 Dec; 316(22):2373-2384. PubMed ID: 27846344 [TBL] [Abstract][Full Text] [Related]
36. Relationships between nutrient intake and progression/regression of coronary atherosclerosis as assessed by serial quantitative angiography. Watts GF; Lewis B; Jackson P; Burke V; Lewis ES; Brunt JN; Coltart DJ Can J Cardiol; 1995 Oct; 11 Suppl G():110G-114G. PubMed ID: 7585283 [TBL] [Abstract][Full Text] [Related]